August 2012
-
The FDA has approved MedImmune’s FluMist Quadrivalent for the prevention of influenza, making the intranasal vaccine the first approved quadrivalent flu vaccine in the US. FluMist Quadrivalent contains two type A strains and type B… Read more . . .
-
To celebrate its 200th anniversary, the New England Journal of Medicine (NEJM) is publishing a series of special articles reviewing progress in medicine since 1812. As part of the series, an article in the March… Read more . . .
-
Engineered BioPharmaceuticals, Inc. (eBio) currently has an opening for an entry level process design engineer at its Danville,VA manufacturing site. As a member of a fast paced, highly motivated team, you will assist with all… Read more . . .
-
Since 1968, ABC Laboratories has delivered expert scientific support to companies working to improve human and animal health. As a member of the ABC Team, you’ll work alongside respected technical experts dedicated to scientific excellence… Read more . . .
-
Since 1968, ABC Laboratories has delivered expert scientific support to companies working to improve human and animal health. As a member of the ABC Team, you’ll work alongside respected technical experts dedicated to scientific excellence… Read more . . .
-
Since 1968, ABC Laboratories has delivered expert scientific support to companies working to improve human and animal health. As a member of the ABC Team, you’ll work alongside respected technical experts dedicated to scientific excellence… Read more . . .
-
Since 1968, ABC Laboratories has delivered expert scientific support to companies working to improve human and animal health. As a member of the ABC Team, you’ll work alongside respected technical experts dedicated to scientific excellence… Read more . . .
-
A company called GSC Products has launched what it says is “the world’s first caffeine nasal spray” in the US. GSC says that the product, called Turbo Snort, was introduced on the Internet in January… Read more . . .
-
Forest Laboratories has received EMA approval to market Colobreathe dry powder colistimethate sodium inhalation powder for the treatment of P. aeruginosa infections in cystic fibrosis patients aged 6 years and older, according to the company.… Read more . . .
-
The FDA’s Pulmonary-Allergy Drugs Advisory Committee (PADAC) has voted 12 to 2 in favor of approval for Forest Laboratories’ and Almirall’s NDA for a 400 μg twice daily dose aclidinium bromide inhalation powder to treat… Read more . . .
Featured event:
5th Annual Inhaled & Nasal Biologics | DNA Forum
5th Annual Inhaled & Nasal Biologics | DNA Forum
24th-25th September 2026, Cambridge, UK
Join us for a ground-breaking and insightful forum: Two days of cutting-edge talks and networking opportunities in this complex area of drug and vaccine development.
With renowned industry leaders who will share their insights and real-world case studies, our speakers will explore innovative formulation and delivery technologies and the rationale behind overcoming development challenges. Don’t miss out on this opportunity to learn more about key topics shaping the future of inhaled therapeutics.
Get online to see speakers announced so far. Registration is live – save your seat now!
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden
October 21-October 22: MVIC Symposium, Lund, Sweden
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland